Creating a specific quality-of-life questionnaire in patients with glaucoma: Item generation;Création d'un questionnaire spécifique évaluant la qualité de vie chez les patients glaucomateux: La génération des items

Journal Francais d'Ophtalmologie

Volumn 25, Issue 8, 2002, Pages 785-794

  Rouland, J F ^a   Denis, P ^b   Bechetoille A ^c   Rigeade, M C ^c   Brouquet, Y ^d   Arnould, B ^e   Baudouin, C ^f   Renard, J P ^g   Bron, A ^h   Nordmann, J P ^f   Sellem, E ⁱ  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c Chauvin Bausch and Lomb ^*

^d Laboratoires Bausch and Lomb/Chauvin   (France)

^e MAPI VALUES   (United States)

^f CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^g University of Paris Descartes   (France)

^h HÔPITAL DU BOCAGE   (France)

ⁱ Centre D'ophtalmologie Kléber   (France)

Author keywords

Chronic glaucoma; Item generation; Primary open angle glaucoma (POAG); Quality of life (QoL); Questionnaire development

Indexed keywords

ARTICLE; CLINICAL RESEARCH; DAILY LIFE ACTIVITY; GLAUCOMA; HUMAN; MOOD; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; VALIDATION PROCESS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 0036808088     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Schipper H, Clinch J et al. Definitions and conceptual issues. In: Spilker B ed. Quality of Life Assessments in Clinical Trials. New York: Raven Press, 1990:11-24.
2. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care, 1989;27: S217-32.
3. Groupe d'étude Glaucome et Qualité de Vie. Intérêt de la mesure de la qualité de vie (QDV) et de l'observance thérapeutique chez les patients atteints de glaucome chronique à angle ouvert. J Fr Ophtalmol, 2000;10:1057-64.
4. Juniper EF, Guyatt GH et al. Chapter 6: How to develop and validate a new health related quality of life instrument. In: Spilker B ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd Ed. Philadelphia: Lippincott-Raven Publishers, 1996:49-56.
5. Kessler RC, Mroczek DK. Some methodological issues in the development of the quality of life measures for the evaluation of medical interventions. Journal of Evaluation in Clinical Practice, 1996; 2:181-91.
6. Lee BL, Gutierrez P, Gordon M, Wilson R, Cioffi GA, Ritch R et al. The glaucoma symptom scale. Arch Ophthalmol, 1998; 116:861-6.
7. Sloane ME, Ball K, Owsley C, Bruni JR, Roenker DL. The visual activities questionnaire: Developing an instrument for assessing problems in everyday visual tasks. Tech Diag Noninvasive Assess Vis Sys, 1992;1:26-9.
8. Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD et al. The VF-14. An index of functional impairment in patients with cataract. Arch Ophthalmol, 1994; 112:630-8.
9. Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol, 1998;116:227-33.
10. Ware JE, Sherbourne CA. The MOS 36-item Short Form Health Survey (SF-36). Conceptual frame work and item selection. Med Care, 1992;30:473-83.
11. Laibovitz R, Boyle J, Snyder E, Strohmaier K, Adamsons I. Dorzolamide versus pilocarpine as adjunctive therapies to timolol: A comparison of patient preference and impact on daily life. Clin Ther, 1996; 18:821-32.
12. Demailly Ph, Zoute C, Castro D. Personnalités et glaucome chronique. J Fr Ophtalmol, 1989;12:595-601.